Ventas, Inc. (NYSE:VTR) Receives $90.47 Consensus Target Price from Analysts

Ventas, Inc. (NYSE:VTRGet Free Report) has earned a consensus rating of “Moderate Buy” from the sixteen ratings firms that are covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $90.4667.

Several equities analysts have commented on the company. Wells Fargo & Company increased their target price on Ventas from $88.00 to $93.00 and gave the company an “overweight” rating in a research note on Thursday, March 26th. UBS Group restated a “neutral” rating and issued a $85.00 target price on shares of Ventas in a research note on Monday, February 9th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Ventas in a report on Friday, March 27th. Citigroup raised their price target on shares of Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and issued a $100.00 price target on shares of Ventas in a research note on Monday, February 9th.

Check Out Our Latest Report on Ventas

Ventas Stock Up 0.0%

VTR stock opened at $83.28 on Friday. The firm has a market cap of $39.55 billion, a PE ratio of 154.22, a P/E/G ratio of 2.05 and a beta of 0.75. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67. The firm has a 50 day simple moving average of $83.53 and a 200 day simple moving average of $77.92. Ventas has a 12 month low of $60.15 and a 12 month high of $88.36.

Ventas (NYSE:VTRGet Free Report) last issued its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.74). The business had revenue of ($1,229.71) million during the quarter, compared to analyst estimates of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period last year, the business earned $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities research analysts forecast that Ventas will post 3.4 earnings per share for the current fiscal year.

Ventas Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. This is an increase from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas’s payout ratio is currently 385.19%.

Insider Activity

In related news, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total transaction of $801,606.52. Following the completion of the transaction, the chief executive officer owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. The trade was a 0.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the sale, the executive vice president owned 72,755 shares of the company’s stock, valued at $6,184,175. This trade represents a 32.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.80% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of VTR. NewEdge Advisors LLC boosted its holdings in Ventas by 856.1% during the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after purchasing an additional 7,097 shares during the last quarter. Empowered Funds LLC boosted its stake in shares of Ventas by 6.8% during the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after buying an additional 536 shares during the last quarter. Woodline Partners LP grew its holdings in shares of Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after acquiring an additional 11,739 shares in the last quarter. Focus Partners Wealth grew its holdings in shares of Ventas by 130.4% in the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after acquiring an additional 12,233 shares in the last quarter. Finally, Cetera Investment Advisers increased its position in shares of Ventas by 3.4% in the second quarter. Cetera Investment Advisers now owns 36,918 shares of the real estate investment trust’s stock valued at $2,331,000 after acquiring an additional 1,209 shares during the last quarter. 94.18% of the stock is owned by institutional investors and hedge funds.

Ventas Company Profile

(Get Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Further Reading

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.